Thrivent Financial for Lutherans Has $1.44 Million Stock Holdings in Inspire Medical Systems, Inc. $INSP

Thrivent Financial for Lutherans lowered its stake in Inspire Medical Systems, Inc. (NYSE:INSP) by 82.5% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 19,415 shares of the company’s stock after selling 91,253 shares during the period. Thrivent Financial for Lutherans’ holdings in Inspire Medical Systems were worth $1,441,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. AlphaQuest LLC lifted its position in Inspire Medical Systems by 18.6% during the third quarter. AlphaQuest LLC now owns 3,394 shares of the company’s stock worth $252,000 after acquiring an additional 533 shares during the last quarter. Truist Financial Corp increased its stake in shares of Inspire Medical Systems by 91.5% during the third quarter. Truist Financial Corp now owns 5,299 shares of the company’s stock worth $393,000 after purchasing an additional 2,532 shares during the period. EFG Asset Management North America Corp. lifted its holdings in Inspire Medical Systems by 157.1% during the 3rd quarter. EFG Asset Management North America Corp. now owns 27,634 shares of the company’s stock worth $2,049,000 after purchasing an additional 16,887 shares during the last quarter. Pilgrim Partners Asia Pte Ltd bought a new stake in Inspire Medical Systems in the 3rd quarter valued at $49,000. Finally, Y Intercept Hong Kong Ltd boosted its stake in Inspire Medical Systems by 553.1% in the 3rd quarter. Y Intercept Hong Kong Ltd now owns 99,049 shares of the company’s stock valued at $7,349,000 after purchasing an additional 83,883 shares during the period. 94.91% of the stock is owned by institutional investors.

Inspire Medical Systems Stock Up 0.2%

Shares of Inspire Medical Systems stock opened at $59.78 on Friday. Inspire Medical Systems, Inc. has a 12-month low of $53.11 and a 12-month high of $197.75. The company has a market capitalization of $1.74 billion, a price-to-earnings ratio of 12.00, a PEG ratio of 6.34 and a beta of 0.74. The firm’s 50-day moving average price is $92.88 and its two-hundred day moving average price is $90.99.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Wednesday, February 11th. The company reported $1.65 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.96. The company had revenue of $269.08 million during the quarter, compared to the consensus estimate of $264.02 million. Inspire Medical Systems had a net margin of 15.95% and a return on equity of 10.96%. The firm’s quarterly revenue was up 12.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.15 EPS. On average, sell-side analysts expect that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have weighed in on INSP shares. Wells Fargo & Company set a $70.00 price objective on Inspire Medical Systems and gave the stock an “equal weight” rating in a research report on Thursday. Stifel Nicolaus set a $95.00 price target on shares of Inspire Medical Systems in a research note on Thursday. Wolfe Research cut shares of Inspire Medical Systems from an “outperform” rating to a “peer perform” rating in a research note on Friday. Oppenheimer downgraded shares of Inspire Medical Systems from an “outperform” rating to a “market perform” rating in a report on Thursday, January 22nd. Finally, Robert W. Baird set a $74.00 target price on shares of Inspire Medical Systems and gave the stock a “neutral” rating in a research report on Thursday. Five analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Inspire Medical Systems currently has an average rating of “Hold” and an average target price of $108.94.

Insider Buying and Selling at Inspire Medical Systems

In other news, Director Shawn Mccormick sold 2,000 shares of Inspire Medical Systems stock in a transaction on Friday, November 28th. The stock was sold at an average price of $127.48, for a total value of $254,960.00. Following the transaction, the director owned 26,046 shares in the company, valued at approximately $3,320,344.08. This trade represents a 7.13% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 4.10% of the company’s stock.

Inspire Medical Systems News Roundup

Here are the key news stories impacting Inspire Medical Systems this week:

• Positive Sentiment: Q4 beat: INSP reported $1.65 EPS vs. $0.69 expected and revenue of ~$269M, with expanded gross margins — a near-term operational positive. Zacks: INSP Beats Q4 Estimates
• Positive Sentiment: Some firms remain constructive at reduced targets — Mizuho and Piper Sandler kept outperform/overweight stances after lowering PTs, signaling there’s still perceived upside if reimbursement issues resolve. The Fly: Mizuho PT Cut
• Neutral Sentiment: Earnings call materials and transcript are available for detailed read-through (management commentary on coding, reimbursement and 2026 guide are key). Review to judge whether guidance risks are transitory. Seeking Alpha: Q4 Earnings Call Transcript
• Negative Sentiment: Management issued a 2026 revenue outlook of $950M–$1B and flagged a coding change plus reimbursement headwinds — the primary catalyst for the selloff risk and weaker forward expectations. MSN: 2026 Revenue Outlook & Coding Change
• Negative Sentiment: Multiple analyst downgrades and price-target cuts (Wells Fargo, Baird, Jefferies, Truist and others) followed the guidance and reimbursement concerns, increasing near-term selling pressure. Investing.com: Baird, Wells Fargo Cuts
• Negative Sentiment: The stock already experienced an earlier ~8% intraday decline after the coding/guidance news, showing how sensitive the market is to reimbursement updates. Investing.com: Shares Slide 8%

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.